For example, Guo, et al. [59] reported that the reactivation of p53 by Nutlin-3, and Akt/mTOR inhibition by tanshinone IIA, exhibit a synergetic anti-leukemia effect with imatinib in Philadelphia positive (Ph +) ALL. Here, AKT1 is linked to leukemia.